These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2613708)

  • 1. [Study of diphtheria and tetanus anatoxins by electrofocusing on an agarose gel].
    Bourleaud J
    J Biol Stand; 1989 Oct; 17(4):343-52. PubMed ID: 2613708
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J; Akkermans A; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversibility of toxoids. An improved method of testing.
    Stainer DW; Cameron J
    Dev Biol Stand; 1977; 34():149-53. PubMed ID: 838138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of tolerance to diphtheria-pertussis-tetanus vaccines].
    Künzel W; Meissner C; Lüderitz U; Willkommen H; Winkler C
    Padiatr Grenzgeb; 1986; 25(2-3):197-203. PubMed ID: 3523392
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 8. [A rapid method of measuring the level of aluminum in biological preparations using aluminon].
    Aleksandrowicz J; Fiejka M; Wysokińska T
    Med Dosw Mikrobiol; 1991; 43(3-4):175-80. PubMed ID: 1823380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trace element content and reactivity of DPT adsorbate vaccines].
    Lüderitz P; Marquardt D
    Z Gesamte Hyg; 1985 Jul; 31(7):440. PubMed ID: 3876654
    [No Abstract]   [Full Text] [Related]  

  • 10. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new process of inactivation for preparation of vaccines].
    Relyveld EH; Girard O; Cheyroux M; Asso J; de Rudder J
    Dev Biol Stand; 1974; 27():236-48. PubMed ID: 4218994
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 15. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
    Habbu MK; Poonawalla CS; Parvatikar MS; Jadhav SS
    Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
    Rümke HC
    Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
    [No Abstract]   [Full Text] [Related]  

  • 18. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the stability of the pertussis component of diphtheria-tetanus-pertussis (DTP) vaccines.
    Rao YU; William J; Kalyanaraman VR
    J Biol Stand; 1985 Jul; 13(3):267-70. PubMed ID: 3875613
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
    Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG
    Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.